Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathways

Clinical Immunology

Volumn 124, Issue 2, 2007, Pages 170-181

  Li, Bing ^a   Cramer, Daniel ^a   Wagner, Stephanie ^a   Hansen, Richard ^a   King, Chelsea ^a   Kakar, Shelly ^a   Ding, Chuanlin ^a   Yan, Jun ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

glucan; Cytokine; Macrophage; Pattern recognition receptor; Toll like receptor

Indexed keywords

BETA GLUCAN; CYTOKINE; GLUCAN; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASE SYK; ZYMOSAN;

ADAPTIVE IMMUNITY; ARTICLE; CONTROLLED STUDY; IMMUNOFLUORESCENCE; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; YEAST;

ANIMALS; BETA-GLUCANS; CYTOKINES; GENES, MHC CLASS II; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN-TYROSINE KINASES; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34447300733     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.05.002     Document Type: Article

References (40)

1. Di Luzio N.R., Williams D.L., McNamee R.B., Edwards B.F., and Kitahama A. Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. Int. J. Cancer 24 (1979) 773-779
2. Williams D.L., Browder I.W., and Di Luzio N.R. Immunotherapeutic modification of Escherichia coli-induced experimental peritonitis and bacteremia by glucan. Surgery 93 (1983) 448-454
3. Tsikitis V.L., Albina J.E., and Reichner J.S. Beta-glucan affects leukocyte navigation in a complex chemotactic gradient. Surgery 136 (2004) 384-389
4. Kournikakis B., Mandeville R., Brousseau P., and Ostroff G. Anthrax-protective effects of yeast beta 1,3 glucans. MedGenMed 5 (2003) 1
5. Cheung N.K., and Modak S. Oral (1→ 3),(1→4)-beta-d-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma. Clin. Cancer Res. 8 (2002) 1217-1223
6. Hong F., Yan J., Baran J.T., Allendorf D.J., Hansen R.D., Ostroff G.R., Xing P.X., Cheung N.K., and Ross G.D. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J. Immunol. 173 (2004) 797-806
7. Wei D., Zhang L., Williams D.L., and Browder I.W. Glucan stimulates human dermal fibroblast collagen biosynthesis through a nuclear factor-1 dependent mechanism. Wound Repair Regen. 10 (2002) 161-168
8. Vetvicka V., Thornton B.P., and Ross G.D. Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J. Clin. Invest. 98 (1996) 50-61
9. Thornton B.P., Vetvicka V., Pitman M., Goldman R.C., and Ross G.D. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 156 (1996) 1235-1246
10. Xia Y., Vetvicka V., Yan J., Hanikyrova M., Mayadas T., and Ross G.D. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J. Immunol. 162 (1999) 2281-2290
11. Yan J., Vetvicka V., Xia Y., Coxon A., Carroll M.C., Mayadas T.N., and Ross G.D. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). J. Immunol. 163 (1999) 3045-3052
12. Hong F., Hansen R.D., Yan J., Allendorf D.J., Baran J.T., Ostroff G.R., and Ross G.D. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res. 63 (2003) 9023-9031
13. Yan J., Allendorf D.J., and Brandley B. Yeast whole glucan particle (WGP) beta-glucan in conjunction with antitumour monoclonal antibodies to treat cancer. Expert Opin. Biol. Ther. 5 (2005) 691-702
14. Cramer D.E., Allendorf D.J., Baran J.T., Hansen R., Marroquin J., Li B., Ratajczak J., Ratajczak M.Z., and Yan J. {beta}-Glucan enhances complement-mediated hematopoietic recovery after bone marrow injury. Blood 107 (2006) 835-840
15. Brown G.D., and Gordon S. Immune recognition. A new receptor for beta-glucans. Nature 413 (2001) 36-37
16. Brown G.D., Taylor P.R., Reid D.M., Willment J.A., Williams D.L., Martinez-Pomares L., Wong S.Y., and Gordon S. Dectin-1 is a major beta-glucan receptor on macrophages. J. Exp. Med. 196 (2002) 407-412
17. Brown G.D., Herre J., Williams D.L., Willment J.A., Marshall A.S., and Gordon S. Dectin-1 mediates the biological effects of beta-glucans. J. Exp. Med. 197 (2003) 1119-1124
18. Gantner B.N., Simmons R.M., Canavera S.J., Akira S., and Underhill D.M. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197 (2003) 1107-1117
19. Herre J., Marshall A.S., Caron E., Edwards A.D., Williams D.L., Schweighoffer E., Tybulewicz V., Reis e Sousa C., Gordon S., and Brown G.D. Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood 104 (2004) 4038-4045
20. Saijo S., Fujikado N., Furuta T., Chung S.H., Kotaki H., Seki K., Sudo K., Akira S., Adachi Y., Ohno N., Kinjo T., Nakamura K., Kawakami K., and Iwakura Y. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 8 (2007) 39-46
21. Taylor P.R., Tsoni S.V., Willment J.A., Dennehy K.M., Rosas M., Findon H., Haynes K., Steele C., Botto M., Gordon S., and Brown G.D. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 8 (2007) 31-38
22. Di Carlo F.J., and Fiore J.V. On the composition of zymosan. Science 127 (1958) 756-757
23. Turner M., Schweighoffer E., Colucci F., Di Santo J.P., and Tybulewicz V.L. Tyrosine kinase SYK: essential functions for immunoreceptor signalling. Immunol. Today 21 (2000) 148-154
24. Mocsai A., Abram C.L., Jakus Z., Hu Y., Lanier L.L., and Lowell C.A. Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs. Nat. Immunol. 7 (2006) 1326-1333
25. Berton G., Mocsai A., and Lowell C.A. Src and Syk kinases: key regulators of phagocytic cell activation. Trends Immunol. 26 (2005) 208-214
26. Rogers N.C., Slack E.C., Edwards A.D., Nolte M.A., Schulz O., Schweighoffer E., Williams D.L., Gordon S., Tybulewicz V.L., Brown G.D., and Reis E.S.C. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22 (2005) 507-517
27. Aderem A., and Underhill D.M. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17 (1999) 593-623
28. Brown G.D., and Gordon S. Fungal beta-glucans and mammalian immunity. Immunity 19 (2003) 311-315
29. Gantner B.N., Simmons R.M., and Underhill D.M. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J. 24 (2005) 1277-1286
30. Brown G.D., and Gordon S. Immune recognition of fungal beta-glucans. Cell Microbiol. 7 (2005) 471-479
31. Underhill D.M., Rossnagle E., Lowell C.A., and Simmons R.M. Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood 106 (2005) 2543-2550
32. Taylor P.R., Martinez-Pomares L., Stacey M., Lin H.H., Brown G.D., and Gordon S. Macrophage receptors and immune recognition. Annu. Rev. Immunol. 23 (2005) 901-944
33. Ross G.D. Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/alphaMbeta2-integrin glycoprotein. Crit. Rev. Immunol. 20 (2000) 197-222
34. Rice P.J., Kelley J.L., Kogan G., Ensley H.E., Kalbfleisch J.H., Browder I.W., and Williams D.L. Human monocyte scavenger receptors are pattern recognition receptors for (1→3)-beta-d-glucans. J. Leukocyte Biol. 72 (2002) 140-146
35. Zimmerman J.W., Lindermuth J., Fish P.A., Palace G.P., Stevenson T.T., and DeMong D.E. A novel carbohydrate-glycosphingolipid interaction between a beta-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J. Biol. Chem. 273 (1998) 22014-22020
36. Taylor P.R., Brown G.D., Herre J., Williams D.L., Willment J.A., and Gordon S. The role of SIGNR1 and the beta-glucan receptor (dectin-1) in the nonopsonic recognition of yeast by specific macrophages. J. Immunol. 172 (2004) 1157-1162
37. Lebron F., Vassallo R., Puri V., and Limper A.H. Pneumocystis carinii cell wall beta-glucans initiate macrophage inflammatory responses through NF-kappaB activation. J. Biol. Chem. 278 (2003) 25001-25008
38. Willment J.A., Lin H.H., Reid D.M., Taylor P.R., Williams D.L., Wong S.Y., Gordon S., and Brown G.D. Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. J. Immunol. 171 (2003) 4569-4573
39. Sato T., Iwabuchi K., Nagaoka I., Adachi Y., Ohno N., Tamura H., Seyama K., Fukuchi Y., Nakayama H., Yoshizaki F., Takamori K., and Ogawa H. Induction of human neutrophil chemotaxis by Candida albicans-derived beta-1,6-long glycoside side-chain-branched beta-glucan. J. Leukocyte Biol. 80 (2006) 204-211
40. Ulanova M., Puttagunta L., Marcet-Palacios M., Duszyk M., Steinhoff U., Duta F., Kim M.K., Indik Z.K., Schreiber A.D., and Befus A.D. Syk tyrosine kinase participates in beta1-integrin signaling and inflammatory responses in airway epithelial cells. Am. J. Physiol.: Lung Cell. Mol. Physiol. 288 (2005) L497-L507